Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Launch75441 grounded factsnewest July 16, 2026, 9:02 AM ETRSS · JSON
Showing 7201–7250 of 33107
Departed
Grant Verstandig
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Zhengbin (Bing) Yao
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
Tim Bertram
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Departed
(interim)
Albert N. Marchio II
Interim Chief Financial Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Mathias Oelke
Chief Scientific Officer
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
Departed
Paul D'Angio
Director
NexImmune, Inc.
Effective
2024-08-27
Successor
Craig Jalbert
Filed
August 27, 2024, 7:59 PM ET
On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
Patrick C. Graney III, a member of the Board of Directors (the “Board”) of Truist Financial Corporation (“Truist”), notified Truist of his decision to retire from the Board effective August 31, 2024.
On August 21, 2024, Mr. Bonaccorso notified Verrica Pharmaceuticals Inc. (the “Company”) that he will resign from his position as Chief Commercial Officer of the Company, effective August 30, 2024.
On August 21, 2024, Mr. Don Kalkofen tendered his resignation as Chief Financial Officer of Alpha Cognition Inc. (the “Company”), effective October 1, 2024.
On August 26, 2024, Johnson & Johnson (the Company) issued a press release announcing that Peter M. Fasolo, Executive Vice President, Chief Human Resources Officer (CHRO), has elected to retire.
Departed
Richard K. Coleman, Jr.
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Star Equity Holdings, Inc. (the “Company”) determined that Richard K. Coleman, Jr. will not stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting.
Departed
Michael A. Cunnion
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Michael A. Cunnion notified the Company of his decision not to stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting, to permit him to focus his time and energy on other business ventures.
Departed
John W. Sayward
Director
STAR EQUITY HOLDINGS, INC.
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, John W. Sayward notified the Company of his decision not to stand for reelection as a director of the Company at the Company’s 2024 Annual Stockholder Meeting, to permit him to focus his time and energy on other business ventures.
On August 23, 2024, Erin Brockovich, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), notified the Company of her resignation as a member of the Board and any committees of the Board, effective August 26, 2024.
Departed
Jeroen Decleer
Senior Vice President and President of Off-Highway Drive and Motion Systems
W. Bryan Buckler’s notification to the Company on August 20, 2024 of his decision to resign his position as Chief Financial Officer of OGE Energy and OG&E effective August 29, 2024.
On August 26, 2024, W.W. Grainger, Inc. (the “Company”) announced that Matthew E. Fortin, Senior Vice President and Chief Human Resources Officer of the Company, is no longer with the Company effective August 23, 2024.
On August 25, 2024, Marcin Urbaszek notified the Board of Directors (the “ Board ”) of Granite Point Mortgage Trust Inc. (the “ Company ”) that he intends to voluntarily resign as Chief Financial Officer of the Company effective December 1, 2024
On August 23, 2024, Mr. Zvi Lando notified the Board of Directors (the “Board”) of SolarEdge Technologies, Inc. (the “Company”) of his resignation from the role of Chief Executive Officer of the Company (“CEO”), effective as of August 26, 2024 (the “Effective Date”).
determined that John Bencich will no longer serve as the Company’s Chief Executive Officer, “principal executive officer” or “principal financial officer,” effective as of August 21, 2024
Departed
Ryan J. Faulkingham
Chief Financial Officer
Compass Group Diversified Holdings LLC
Effective
2024-08-30
Successor
Stephen Keller
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Compass Group Diversified Holdings LLC (the “Company”) and Compass Diversified Holdings (the “Trust”) (NYSE: CODI) announced the departure of Ryan J. Faulkingham as the Chief Financial Officer of the Company and as a regular trustee of the Trust, each effective as of August 30, 2024.
Departed
Michael Thompson
Director
Odyssey Semiconductor Technologies, Inc.
Effective
2024-08-19
Filed
August 26, 2024, 7:59 PM ET
Richard Ogawa and Michael Thompson, directors of the Company, respectively notified the Company of their intent to resign their positions as directors of the Company.
Departed
Richard Ogawa
Director
Odyssey Semiconductor Technologies, Inc.
Effective
2024-08-19
Filed
August 26, 2024, 7:59 PM ET
Richard Ogawa and Michael Thompson, directors of the Company, respectively notified the Company of their intent to resign their positions as directors of the Company.
Departed
J. Tyler Opel
director
AmeriCann, Inc.
Effective
2024-08-23
Filed
August 26, 2024, 7:59 PM ET
On August 23, 2024 J. Tyler Opel resigned as a director of the Company.
On August 26, 2024, LeMaitre Vascular, Inc. (the “Company”), announced that Joseph P. Pellegrino, Jr. will retire as an employee of the company, including as Chief Financial Officer, effective as of March 7, 2025, following the anticipated filing of the 2024 Fiscal Year 10-K.
Effective August 23,2024, Steve Handy resigned as the Chief Financial Officer of Sacks Parente Golf, Inc. (the “Company”) to take the position of Chief Financial Officer of RDE, Inc.(Nasdaq:RSTN).
Departed
Thomas A. Bock
Chief Executive Officer
Notable Labs, Ltd.
Effective
2024-08-26
Successor
Joseph Wagner
Filed
August 26, 2024, 7:59 PM ET
On August 26, 2024, Dr. Thomas A. Bock resigned from his positions as Director and as Chief Executive Officer of Notable Labs, Ltd.
On August 20, 2024, Andrés Meza submitted his notice of intent to resign as Chief Operating Officer of the Company, effective September 1, 2024 (the “Resignation Date”).
Mr. Deno will retire from the Board and his role as Chief Executive Officer effective September 3, 2024 and will remain employed by the Company through December 31, 2024 as a transition period at his current rate of base salary and receive his 2024 bonus following his departure at the estimated level of Company performance.
Departed
Brett Patterson
Executive Vice President, President of Outback Steakhouse
Brett Patterson, the Company’s Executive Vice President, President of Outback Steakhouse, has resigned from the Company effective as of September 27, 2024 as he has accepted a position at another company.
On August 26, 2024, Criteo S.A. (the “Company”) announced that Megan Clarken, the Chief Executive Officer of the Company, will retire from the Company after completion of a search process for her successor and a transition period.
Departed
Danelle Barrett
Director
Federal Home Loan Bank of New York
Effective
2024-08-21
Filed
August 26, 2024, 7:59 PM ET
On August 21, 2024, the Federal Home Loan Bank of New York (“FHLBNY”) was informed by FHLBNY Independent Director Danelle Barrett that she would, for health reasons, be resigning from the FHLBNY’s Board of Directors effective as of the close of FHLBNY business on August 21, 2024.
Departed
Andrea Webb
Executive Vice President, Chief Customer Officer
SolarWinds Corp
Effective
2024-12-02
Filed
August 26, 2024, 7:59 PM ET
On August 22, 2024, Andrea Webb notified SolarWinds Corporation (the “ Company ”) of her decision to resign as the Company’s Executive Vice President, Chief Customer Officer effective as of December 2, 2024.
Departed
Deeksha Hebbar
Chief Operating Officer
Sonder Holdings Inc.
Effective
2024-08-31
Filed
August 26, 2024, 7:59 PM ET
On August 22, 2024, Deeksha Hebbar resigned as our Chief Operating Officer, effective August 31, 2024.
On August 20, 2024, The Progressive Corporation (the “Company”) was informed that Danelle M. Barrett, a member of the Board of Directors (the “Board”), intended to resign from the Board.
Ms. Landau, who was appointed to the Board as the designee of Bank Leumi, has separated from employment with Bank Leumi, and in connection with the Notice, Ms. Landau has tendered her resignation from the Board.
Scott Honour informed Pineapple Energy Inc. (the "Company") of his decision to resign from the Board of Directors (the "Board"), effective as of the date a successor director was appointed, which was August 22, 2024, as described below.
Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024.
Brian J. Wendling, Principal Financial Officer and Chief Accounting Officer of the Company, and Renee L. Wilm, Chief Legal Officer and Chief Administrative Officer of the Company, will step down from their officer positions, effective August 31, 2024.
Departed
Renee L. Wilm
Chief Legal Officer and Chief Administrative Officer
Brian J. Wendling, Principal Financial Officer and Chief Accounting Officer of the Company, and Renee L. Wilm, Chief Legal Officer and Chief Administrative Officer of the Company, will step down from their officer positions, effective August 31, 2024.
Departed
Gregory B. Maffei
President, Chief Executive Officer, Chairman of the Board
On August 21, 2024, Gregory B. Maffei notified the Company of his resignation as President, Chief Executive Officer, Chairman of the Board and a director of the Company effective August 31, 2024.
Ronald D. Webb, Vice President, Chief Human Resource Officer, notified the California Water Service Group (the “Company”) of his intention to retire effective after the close of business on March 31, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.